Moscow Laboratory Group Gemotest Expands Cooperation with iSOFT

iSOFT Group LimitediSOFT Group Limited announces - The Gemotest group, one of the five biggest providers of laboratory diagnostic services in Moscow, expands its central laboratory network by integrating the iSOFT Laboratory Module for microbiology. After the successful implementation of the iSOFT laboratory information system in 2008 the diagnostics provider now wants to further expand its service profile in order to continue the set growth strategy in the future. The further development of the cooperation enables iSOFT to step forward into the Russian healthcare market and successfully widen its footprint in Eastern Europe.

Within this new project Gemotest will install the new iSOFT Laboratory microbiology module in the overarching network in its central laboratory in Moscow. In combination with the existing iSOFT Laboratory components the results of microbiological analysis will be integrated reliably into the workflow. This enables Gemotest to extend its services for special laboratory diagnostic examinations. Moreover, the high flexibility and scalability of the entire laboratory system allows for the implementation of additional 10 analytical devices into the IT environment of the laboratory group as well as the smooth set up of further working stations.

By this diversification Gemotest intends to increase its competitive position and win further market shares in the field of special laboratory diagnostic examinations. This aspect is an essential building block for the growth plans of the Russian diagnostics service provider.

"With Gemotest we found a partner in the Russian market, who already successfully implements modern IT systems for the management of workflow processes," said Peter Herrmann, Managing Director, iSOFT Health. "The Russian healthcare market with a total volume of approximately two billion U.S. Dollars and constant growth rates in the last few years is a key market for iSOFT. That's why it is particularly important to have strong regional partners and reference sites, who can serve as "Proof of Concept" for further potential customers."

The order allows Gemotest the implementation of a comprehensive laboratory infrastructure, which provides the necessary scalability to integrate additional devices and locations into the existing IT environment. To take advantage of this flexibility and scalability, Gemotest invested a total of approximately €100.000 in the expansion of the laboratory IT system as well as for support and system maintenance over five years.

Related news articles:

About Gemotest
The Moscow-based laboratory group Gemotest has entrusted more than 100 employees with the provision of diagnostic services. Every day up to 11,000 samples are analyzed and processed. The company, which for years pursued clear growth strategy, plans in the next years to establish other laboratory facilities in Russia and is one of the fastest-growing laboratory service providers in the country.

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists in 19 locations worldwide, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...